Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
The report details the trend, potential and market size of Autoimmune Drugs market, and analyzes the current situation and prospects of the market from both qualitative and quantitative aspects, which can be roughly divided into three parts.
The first part (Chapter1-7) mainly covers the qualitative analysis of Autoimmune Drugsmarket, defines the market attractiveness level of Autoimmune Drugs market through Porter's Five Forces Analysis, and summarizes the different factors in the overall environment through PEST analysis. Understand the distribution of industrial chain value in each link of industrial chain through the analysis of industrial chain structure. Thus estimate the market space of each link.
The second part (Chapter8-12), based on the segmentation of Autoimmune Drugs industry, describes the types of Autoimmune Drugs market, the applications of major players and the market size, and deeply analyzes the current situation of the global Autoimmune Drugs market and the development prospects and opportunities of Autoimmune Drugs industry.
The third part (Chapter14-15) includes the market positions of the major players and information on the market participants, which will help you gain a comprehensive understanding of the current competitive situation and potential growth opportunities in the market.
As COVID-19 continues to impact the global economy in 2022, the report also considers the short - and long-term impacts of COVID-19 on the global Autoimmune Drugs market in Chapter 13.
By Player:
Pfizer
GSK
Eli Lilly
Biogen
AbbVie
Amgen
Baxter
Johnson & Johnson
Roche
By Type:
Rheumatoid Arthritis (RA)
Multiple Sclerosis (MS)
Psoriasis
Inflammatory Bowel Disease (IBD)
Ankylosing Spondylitis (AS)
Systemic Lupus Erythematosus (SLE)
By End-User:
Hospitals
Homecare Settings
Specialty Clinics
By Geography:
-
United States
-
Europe
-
China
-
Japan
-
India
-
South Korea
TABLE OF CONTENT
1 Introduction
-
1.1 Market Definition
-
1.2 Market Segment Analysis
-
1.3 Market Size 2022
-
1.4 Autoimmune Drugs Market Outlook: Forecast for 2022 - 2028
-
1.5 Pricing Analysis
2 Executive Summary
3 Autoimmune Drugs Market Lineage Outlook
-
3.1 Parent Market Outlook
-
3.2 Related/Ancillary Market Outlook
-
3.3 Penetration & Growth Prospect Mapping, 2022
4 Market Analysis Tools: Porter's Five Forces
-
4.1 Supplier Power
-
4.2 Buyer Power
-
4.3 Substitution Threat
-
4.4 Threat of New Entrants
-
4.5 Competitive Rivalry
5 Autoimmune Drugs Industry Analysis - PEST (Political & Legal, Economic, Social, and Technological)
-
5.1 Political/Legal Landscape
-
5.2 Economic Landscape
-
5.3 Social Landscape
-
5.4 Technology Landscape
6 Autoimmune Drugs Market - Value Chain Analysis
-
6.1 Industry's Value Chain Analysis
-
6.2 Product Life Cycle
-
6.3 User Perspective Analysis
7 Region and Country-wise Autoimmune Drugs Market Analysis and Outlook to 2022
-
7.1 Global Autoimmune Drugs Consumption (2017-2022)
-
7.2 United States Autoimmune Drugs Consumption (2017-2022)
-
7.3 Europe Autoimmune Drugs Consumption (2017-2022)
-
7.4 China Autoimmune Drugs Consumption (2017-2022)
-
7.5 Japan Autoimmune Drugs Consumption (2017-2022)
-
7.6 India Autoimmune Drugs Consumption (2017-2022)
-
7.7 South Korea Autoimmune Drugs Consumption (2017-2022)
8 Region and Country-wise Autoimmune Drugs Market Analysis and Outlook to 2028
-
8.1 Global Autoimmune Drugs Consumption Forecast (2022-2028)
-
8.2 United States Autoimmune Drugs Consumption Forecast (2022-2028)
-
8.3 Europe Autoimmune Drugs Consumption Forecast (2022-2028)
-
8.4 China Autoimmune Drugs Consumption Forecast (2022-2028)
-
8.5 Japan Autoimmune Drugs Consumption Forecast (2022-2028)
-
8.6 India Autoimmune Drugs Consumption Forecast (2022-2028)
-
8.7 South Korea Autoimmune Drugs Consumption Forecast (2022-2028)
9 Global Autoimmune Drugs Market Outlook by Types and Applications to 2022
-
9.1 Global Autoimmune Drugs Consumption and Growth Rate by Type (2017-2022)
-
9.1.1 Global Rheumatoid Arthritis (RA) Consumption and Growth Rate (2017-2022)
-
9.1.2 Global Multiple Sclerosis (MS) Consumption and Growth Rate (2017-2022)
-
9.1.3 Global Psoriasis Consumption and Growth Rate (2017-2022)
-
9.1.4 Global Inflammatory Bowel Disease (IBD) Consumption and Growth Rate (2017-2022)
-
9.1.5 Global Ankylosing Spondylitis (AS) Consumption and Growth Rate (2017-2022)
-
9.1.6 Global Systemic Lupus Erythematosus (SLE) Consumption and Growth Rate (2017-2022)
-
9.2 Global Autoimmune Drugs Consumption and Growth Rate by Application (2017-2022)
-
9.2.1 Global Hospitals Consumption and Growth Rate (2017-2022)
-
9.2.2 Global Homecare Settings Consumption and Growth Rate (2017-2022)
-
9.2.3 Global Specialty Clinics Consumption and Growth Rate (2017-2022)
10 Global Autoimmune Drugs Market Outlook by Types and Applications to 2028
-
10.1 Global Autoimmune Drugs Consumption Forecast and Growth Rate by Type (2022-2028)
-
10.1.1 Global Rheumatoid Arthritis (RA) Consumption Forecast and Growth Rate (2022-2028)
-
10.1.2 Global Multiple Sclerosis (MS) Consumption Forecast and Growth Rate (2022-2028)
-
10.1.3 Global Psoriasis Consumption Forecast and Growth Rate (2022-2028)
-
10.1.4 Global Inflammatory Bowel Disease (IBD) Consumption Forecast and Growth Rate (2022-2028)
-
10.1.5 Global Ankylosing Spondylitis (AS) Consumption Forecast and Growth Rate (2022-2028)
-
10.1.6 Global Systemic Lupus Erythematosus (SLE) Consumption Forecast and Growth Rate (2022-2028)
-
10.2 Global Autoimmune Drugs Consumption Forecast and Growth Rate by Application (2022-2028)
-
10.2.1 Global Hospitals Consumption Forecast and Growth Rate (2022-2028)
-
10.2.2 Global Homecare Settings Consumption Forecast and Growth Rate (2022-2028)
-
10.2.3 Global Specialty Clinics Consumption Forecast and Growth Rate (2022-2028)
11 Global Autoimmune Drugs Import and Export Analysis (Top 5 Countries)
-
11.1 Global Autoimmune Drugs Import by Region (Top 5 Countries) (2017-2028)
-
11.2 Global Autoimmune Drugs Export by Region (Top 5 Countries) (2017-2028)
12 Coronavirus Disease (COVID-19) Impact
-
12.1 Industry Impact Analysis
-
12.2 Autoimmune Drugs Market Outlook to 2028 - COVID-19 Affected Forecasts
13 Competition Matrix
-
13.1 Target Markets
-
13.2 Comprehensive Analysis of Products in Competitive Markets
14 Global Autoimmune Drugs Market Competitive Analysis
-
14.1 Pfizer
-
14.1.1 Pfizer Company Details
-
14.1.2 Pfizer Autoimmune Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
14.1.3 Pfizer Autoimmune Drugs Product and Service
-
14.2 GSK
-
14.2.1 GSK Company Details
-
14.2.2 GSK Autoimmune Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
14.2.3 GSK Autoimmune Drugs Product and Service
-
14.3 Eli Lilly
-
14.3.1 Eli Lilly Company Details
-
14.3.2 Eli Lilly Autoimmune Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
14.3.3 Eli Lilly Autoimmune Drugs Product and Service
-
14.4 Biogen
-
14.4.1 Biogen Company Details
-
14.4.2 Biogen Autoimmune Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
14.4.3 Biogen Autoimmune Drugs Product and Service
-
14.5 AbbVie
-
14.5.1 AbbVie Company Details
-
14.5.2 AbbVie Autoimmune Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
14.5.3 AbbVie Autoimmune Drugs Product and Service
-
14.6 Amgen
-
14.6.1 Amgen Company Details
-
14.6.2 Amgen Autoimmune Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
14.6.3 Amgen Autoimmune Drugs Product and Service
-
14.7 Baxter
-
14.7.1 Baxter Company Details
-
14.7.2 Baxter Autoimmune Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
14.7.3 Baxter Autoimmune Drugs Product and Service
-
14.8 Johnson & Johnson
-
14.8.1 Johnson & Johnson Company Details
-
14.8.2 Johnson & Johnson Autoimmune Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
14.8.3 Johnson & Johnson Autoimmune Drugs Product and Service
-
14.9 Roche
-
14.9.1 Roche Company Details
-
14.9.2 Roche Autoimmune Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
14.9.3 Roche Autoimmune Drugs Product and Service
15 Appendix
TABLE OF CHARTS
-
Table Definition of Autoimmune Drugs
-
Figure Autoimmune Drugs Picture
-
Table Global Autoimmune Drugs Market Size and Forecast 2022 - 2028 (USD million)
-
Figure Global Autoimmune Drugs Market Size and Forecast 2022 - 2028 (USD million)
-
Figure Global Autoimmune Drugs Market: Year-over-year Growth 2022 - 2028 (%)
-
Table Parent Market Analysis
-
Figure Parent Market Price
-
Table Related/Ancillary Market Outlook Analysis
-
Table Supplier Power Analysis
-
Table Buyer Power Analysis
-
Table Substitution Threat Analysis
-
Table Threat of New Entrants Analysis
-
Table Competitive Rivalry Analysis
-
Figure Global Autoimmune Drugs Consumption by Country (2017-2022)
-
Figure United States Autoimmune Drugs Consumption and Growth Rate (2017-2022)
-
Table Europe Autoimmune Drugs Consumption and Growth Rate (2017-2022)
-
Figure China Autoimmune Drugs Consumption and Growth Rate (2017-2022)
-
Figure Japan Autoimmune Drugs Consumption and Growth Rate (2017-2022)
-
Figure India Autoimmune Drugs Consumption and Growth Rate (2017-2022)
-
Figure South Korea Autoimmune Drugs Consumption and Growth Rate (2017-2022)
-
Figure Global Autoimmune Drugs Consumption Forecast by Country (2022-2028)
-
Figure United States Autoimmune Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Table Europe Autoimmune Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure China Autoimmune Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure Japan Autoimmune Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure India Autoimmune Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure South Korea Autoimmune Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Rheumatoid Arthritis (RA) Consumption and Growth Rate (2017-2022)
-
Figure Global Multiple Sclerosis (MS) Consumption and Growth Rate (2017-2022)
-
Figure Global Psoriasis Consumption and Growth Rate (2017-2022)
-
Figure Global Inflammatory Bowel Disease (IBD) Consumption and Growth Rate (2017-2022)
-
Figure Global Ankylosing Spondylitis (AS) Consumption and Growth Rate (2017-2022)
-
Figure Global Systemic Lupus Erythematosus (SLE) Consumption and Growth Rate (2017-2022)
-
Figure Global Hospitals Consumption and Growth Rate (2017-2022)
-
Figure Global Homecare Settings Consumption and Growth Rate (2017-2022)
-
Figure Global Specialty Clinics Consumption and Growth Rate (2017-2022)
-
Figure Global Rheumatoid Arthritis (RA) Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Multiple Sclerosis (MS) Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Psoriasis Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Inflammatory Bowel Disease (IBD) Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Ankylosing Spondylitis (AS) Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Systemic Lupus Erythematosus (SLE) Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Hospitals Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Homecare Settings Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Specialty Clinics Consumption Forecast and Growth Rate (2022-2028)
-
Table Global Autoimmune Drugs Import by Region (Top 5 Countries) (2017-2028)
-
Table Global Autoimmune Drugs Export by Region (Top 5 Countries) (2017-2028)
-
Table Pfizer (Foundation Year, Company Profile and etc.)
-
Table Pfizer Autoimmune Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table Pfizer Autoimmune Drugs Product and Service
-
Table GSK (Foundation Year, Company Profile and etc.)
-
Table GSK Autoimmune Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table GSK Autoimmune Drugs Product and Service
-
Table Eli Lilly (Foundation Year, Company Profile and etc.)
-
Table Eli Lilly Autoimmune Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table Eli Lilly Autoimmune Drugs Product and Service
-
Table Biogen (Foundation Year, Company Profile and etc.)
-
Table Biogen Autoimmune Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table Biogen Autoimmune Drugs Product and Service
-
Table AbbVie (Foundation Year, Company Profile and etc.)
-
Table AbbVie Autoimmune Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table AbbVie Autoimmune Drugs Product and Service
-
Table Amgen (Foundation Year, Company Profile and etc.)
-
Table Amgen Autoimmune Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table Amgen Autoimmune Drugs Product and Service
-
Table Baxter (Foundation Year, Company Profile and etc.)
-
Table Baxter Autoimmune Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table Baxter Autoimmune Drugs Product and Service
-
Table Johnson & Johnson (Foundation Year, Company Profile and etc.)
-
Table Johnson & Johnson Autoimmune Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table Johnson & Johnson Autoimmune Drugs Product and Service
-
Table Roche (Foundation Year, Company Profile and etc.)
-
Table Roche Autoimmune Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table Roche Autoimmune Drugs Product and Service
-
